• 1988 - Founded in Emeryville, CA
• 1990 - BiosPacific partners with Fortron Biosciences to manufacture a line of AP Polyclonals including TnI antibodies
• 1994 - Fortron files for patent protection on the G-129-C & G-130-C polyclonal antibodies
• 2004 - BiosPacific is granted exclusive distribution rights in US for MedixMAb monoclonals from Medix Biochemica
• 2005 - Techne Corporation acquires BiosPacific & Fortron
• 2011 - BiosPacific achieves ISO 9001:2008 Certification
• 2014 - Techne Corp, our parent company, changes it's operating name to Bio-Techne to better reflect the combined strengths of all of its existing brands.